Contact us at 914-666-4665

Filter posts by category

Lyme Science Blog

WHO DISCOVERED LYME DISEASE

Willy Burgdorfer and the Discovery of Lyme Disease

Willy Burgdorfer and the Discovery of Lyme Disease By Alan MacDonald, M.D. Guest Blog Dr. Willy Burgdorfer’s discovery of the bacterium responsible for Lyme disease transformed modern medicine—and his legacy continues to shape how we understand this complex illness today. Willy Burgdorfer’s Lyme disease discovery identified the bacterium Borrelia burgdorferi, establishing Lyme disease as a […]

Willy Burgdorfer and the Discovery of Lyme Disease Read More »

Lyme Disease Canada Debate: Bill C-442 and the Risk of Underestimation

Lyme Disease Canada Debate: Bill C-442 and the Risk of Underestimation The Lyme disease Canada Bill C-442 debate highlights a critical question: is the burden of Lyme disease being underestimated? :contentReference[oaicite:0]{index=0} Although Canadian researchers acknowledge that endemic and at-risk regions for ticks expanded from 1 region in 1997 to 13 regions by 2006, some have

Lyme Disease Canada Debate: Bill C-442 and the Risk of Underestimation Read More »

When Patients Know More Than Doctors

Parents Often Recognize Lyme Disease Symptoms Before Diagnosis Parents may notice Lyme disease symptoms before a diagnosis is made. Children can develop pain, fatigue, walking problems, or behavioral changes. Caregivers often become strong advocates during delayed diagnosis. Guest Blog By Jennifer Bybel Lown, Nurse Practitioner Dr. Daniel Cameron & Associates Lyme disease remains a misunderstood

When Patients Know More Than Doctors Read More »

Borrelia miyamotoi FDA test

Where is the FDA test for relapsing fever spirochete, Borrelia miyamotoi?

Borrelia miyamotoi Testing Highlights Limits of FDA-Approved Lyme Tests Emerging tick-borne infections may require specialized testing. Borrelia miyamotoi can resemble Lyme disease and relapsing fever. Concerns remain about restricting access to lab developed tests. If the FDA were to limit clinicians to only FDA-approved diagnostic testing for tick-borne diseases, access to specialized laboratory testing could

Where is the FDA test for relapsing fever spirochete, Borrelia miyamotoi? Read More »

Lyme Disease Treatment: Why One Size Does Not Fit All

Lyme Disease Treatment: Why One Size Does Not Fit All Lyme disease individualized treatment is essential because patients vary widely in symptoms, response to therapy, and clinical course. A uniform approach may not address the complexity of this infection. A review of the International Lyme and Associated Diseases Society (ILADS) 2014 evidence-based guidelines highlights this

Lyme Disease Treatment: Why One Size Does Not Fit All Read More »

FIBROMYALGIA OR LYME DISEASE

Fibromyalgia vs Lyme Disease: Could Your Diagnosis Be Wrong?

Fibromyalgia vs Lyme Disease: Could Your Diagnosis Be Wrong? Fibromyalgia vs Lyme disease is one of the most important diagnostic challenges in chronic illness. Both conditions can involve pain, fatigue, sleep disturbance, headaches, gastrointestinal complaints, and cognitive dysfunction. Many patients are told they have fibromyalgia but continue to struggle despite treatment. Could some cases of

Fibromyalgia vs Lyme Disease: Could Your Diagnosis Be Wrong? Read More »

draft post

The task force by Executive Order must submit an action plan by February 15, 2015, outlining specific steps on how to implement a national strategy to combat antibiotic resistance and accelerate research and development on new antibiotics by 2020. The task force will be led by the secretaries of Health and Human Services, the Department

draft post Read More »

Antibiotic Resistance Policy: Impact on Lyme Disease Treatment

Antibiotic Resistance Policy: Impact on Lyme Disease Treatment Efforts to combat antibiotic resistance are essential—but they may have unintended consequences for patients with Lyme disease. The federal task force established by Executive Order was charged with developing a national strategy to address antibiotic resistance and accelerate the development of new treatments. The task force includes

Antibiotic Resistance Policy: Impact on Lyme Disease Treatment Read More »

Antibiotic Resistance Policy: Impact on Lyme Disease Treatment

Antibiotic Resistance Policy: Impact on Lyme Disease Treatment Efforts to combat antibiotic resistance are essential—but they may have unintended consequences for patients with Lyme disease. The federal task force established by Executive Order was charged with developing a national strategy to address antibiotic resistance and accelerate the development of new treatments. The task force includes

Antibiotic Resistance Policy: Impact on Lyme Disease Treatment Read More »

CAN YOU GET LYME IN OHIO

Can You Get Lyme Disease in Ohio? Cases Are Rising

Can You Get Lyme Disease in Ohio? Cases Are Rising Can you get Lyme disease in Ohio? Yes. Researchers have documented the spread of blacklegged ticks carrying Borrelia burgdorferi, the bacterium associated with Lyme disease, across much of the state. Although Ohio was once considered a low-risk area for Lyme disease, the number of infected

Can You Get Lyme Disease in Ohio? Cases Are Rising Read More »